Older Drugs With Limited Trial Evidence: Are They Worth the Expense?

Research output: Contribution to journal › Article › Academic › peer-review

Access to Document

@article{44de05dcb2d14c308eb2ed69f5080a85,

title = "Older Drugs With Limited Trial Evidence: Are They Worth the Expense?",

author = "Maarten Boers",

year = "2019",

month = oct,

day = "15",

doi = "https://doi.org/10.7326/L19-0518",

language = "English",

volume = "171",

pages = "601",

journal = "Annals of Internal Medicine",

issn = "0003-4819",

publisher = "American College of Physicians",

number = "8",

}

TY - JOUR

T1 - Older Drugs With Limited Trial Evidence

T2 - Are They Worth the Expense?

AU - Boers, Maarten

PY - 2019/10/15

Y1 - 2019/10/15

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85073174475&origin=inward

UR - https://www.ncbi.nlm.nih.gov/pubmed/31610563

U2 - https://doi.org/10.7326/L19-0518

DO - https://doi.org/10.7326/L19-0518

M3 - Article

C2 - 31610563

SN - 0003-4819

VL - 171

SP - 601

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

IS - 8

ER -